Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ad26.COV2-S

Pauciimmune glomerulonephritis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat ALCALA M, et al. WCN24-470 RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS ASSOCIATED IN TIME WITH VACCINATION AGAINST COVID 19. Kidney International Reports 9 (Suppl.): S203-S204 abstr. WCN24-470, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1016/j.ekir.2024.02.416 [abstract] ALCALA M, et al. WCN24-470 RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS ASSOCIATED IN TIME WITH VACCINATION AGAINST COVID 19. Kidney International Reports 9 (Suppl.): S203-S204 abstr. WCN24-470, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1016/j.ekir.2024.02.416 [abstract]
Metadaten
Titel
Ad26.COV2-S
Pauciimmune glomerulonephritis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55856-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Ruxolitinib

Case report

Ceftriaxone

Case report

Adenosine

Case report

Tozinameran

Case report

Antineoplastics

Case report

Multiple drugs